Insomnia Disorder

Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.

Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia

Daridorexant for Alcohol Use Disorder

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)